NEPHROS, INC. Royalty Expense
NEPHROS, INC. (NEPH) reported Royalty Expense of $82.00 thousand for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2019-11-06
- NEPHROS, INC. royalty expense for the quarter ending 2019-09-30 was $82.00K, a 70.83% increase year-over-year.
- NEPHROS, INC. royalty expense for the quarter ending 2019-06-30 was $61.00K, a 69.44% increase year-over-year.
- NEPHROS, INC. royalty expense for the quarter ending 2019-03-31 was $47.00K, a 62.07% increase year-over-year.
- NEPHROS, INC. royalty expense for the quarter ending 2018-12-31 was $48.00K, a 41.18% increase year-over-year.
- NEPHROS, INC. royalty expense for fiscal 2018 was $161.00K, a 64.29% increase from fiscal 2017.
- NEPHROS, INC. royalty expense for fiscal 2017 was $98.00K, a 444.44% increase from fiscal 2016.
- NEPHROS, INC. royalty expense for fiscal 2016 was $18.00K, a 28.57% increase from fiscal 2015.
- NEPHROS, INC. royalty expense for fiscal 2015 was $14.00K.
| Period end | Royalty Expense 3 month | Royalty Expense 6 month | Royalty Expense 9 month | Royalty Expense 12 month |
|---|---|---|---|---|
| 2019-09-30 | $82.00K 10-Q · filed 2019-11-06 | $143.00K derived: sum of 2 quarters · filed 2019-11-06 | $190.00K derived: sum of 3 quarters · filed 2019-11-06 | $238.00K derived: sum of 4 quarters · filed 2019-11-06 |
| 2019-06-30 | $61.00K 10-Q · filed 2019-08-07 | $108.00K 10-Q · filed 2019-08-07 | $156.00K derived: sum of 3 quarters · filed 2019-08-07 | $204.00K derived: sum of 4 quarters · filed 2019-11-06 |
| 2019-03-31 | $47.00K 10-Q · filed 2019-05-08 | $95.00K derived: sum of 2 quarters · filed 2019-05-08 | $143.00K derived: sum of 3 quarters · filed 2019-11-06 | $179.00K derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $96.00K derived: sum of 2 quarters · filed 2019-11-06 | $132.00K derived: sum of 3 quarters · filed 2019-11-06 | $161.00K 10-K · filed 2019-03-12 |
| 2018-09-30 | $48.00K 10-Q · filed 2019-11-06 | $84.00K derived: sum of 2 quarters · filed 2019-11-06 | $113.00K 10-Q · filed 2018-11-08 | $147.00K derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $36.00K 10-Q · filed 2019-08-07 | $65.00K 10-Q · filed 2019-08-07 | $99.00K derived: sum of 3 quarters · filed 2019-08-07 | $121.00K derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $29.00K 10-Q · filed 2019-05-08 | $63.00K derived: sum of 2 quarters · filed 2019-05-08 | $85.00K derived: sum of 3 quarters · filed 2019-05-08 | |
| 2017-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $56.00K derived: sum of 2 quarters · filed 2019-03-12 | $98.00K 10-K · filed 2019-03-12 | |
| 2017-09-30 | $22.00K 10-Q · filed 2018-11-08 | $64.00K 10-Q · filed 2018-11-08 | ||
| 2016-12-31 | $18.00K 10-K · filed 2017-03-20 | |||
| 2015-12-31 | $14.00K 10-K · filed 2017-03-20 | |||
| 2014-09-30 | $4.00K 10-Q · filed 2014-11-13 | $8.00K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |